What is the current valuation of the India virtual clinical-trials market?

The market valuation was $279.0 Million in 2024. Read More

What is the projected market size for the India virtual clinical-trials market by 2035?

The projected valuation for 2035 is $546.0 Million. Read More

What is the expected CAGR for the India virtual clinical-trials market during the forecast period 2025 - 2035?

The expected CAGR is 6.29% during the forecast period. Read More

Which companies are considered key players in the India virtual clinical-trials market?

Key players include Medidata Solutions, Oracle Corporation, Parexel International, and Covance. Read More

What are the main segments of the India virtual clinical-trials market?

Main segments include Study Design, Technology, Therapeutic Area, and Participant Recruitment. Read More

What was the valuation of interventional trials in the India virtual clinical-trials market in 2024?

The valuation for interventional trials was $100.0 Million in 2024. Read More

How much is the mobile health applications segment projected to grow by 2035?

The mobile health applications segment is projected to grow from $70.0 Million to $150.0 Million by 2035. Read More

What is the expected valuation for oncology trials in the India virtual clinical-trials market?

The oncology trials segment is expected to grow from $80.0 Million to $160.0 Million by 2035. Read More

What recruitment methods are utilized in the India virtual clinical-trials market?

Recruitment methods include Direct to Patient, Doctor Referrals, Online Platforms, and Patient Registries. Read More

What is the projected growth for telemedicine platforms in the India virtual clinical-trials market?

The telemedicine platforms segment is projected to grow from $90.0 Million to $200.0 Million by 2035. Read More

India Virtual Clinical Trials Market

ID: MRFR/MED/50025-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

India Virtual Clinical Trials Market Research Report: Size, Share, Trend Analysis By Study Type (Interventional, Observational, Others), By Phase (Phase 1, Phase 2, Phase 3, Phase 4) and By Indication (Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology, Others) - Growth Outlook & Industry Forecast 2025 To 2035

India Virtual Clinical Trials Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Study Design (USD Million)
  1. 4.1.1 Interventional Trials
  2. 4.1.2 Observational Trials
  3. 4.1.3 Registry Trials
  4. 4.1.4 Diagnostic Trials
2. 4.2 Life Sciences, BY Technology (USD Million)
  1. 4.2.1 Wearable Technology
  2. 4.2.2 Mobile Health Applications
  3. 4.2.3 Telemedicine Platforms
  4. 4.2.4 Blockchain Technology
3. 4.3 Life Sciences, BY Therapeutic Area (USD Million)
  1. 4.3.1 Oncology
  2. 4.3.2 Cardiology
  3. 4.3.3 Neurology
  4. 4.3.4 Infectious Diseases
  5. 4.3.5 Endocrinology
4. 4.4 Life Sciences, BY Participant Recruitment (USD Million)
  1. 4.4.1 Direct to Patient
  2. 4.4.2 Doctor Referrals
  3. 4.4.3 Online Platforms
  4. 4.4.4 Patient Registries
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medidata Solutions (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Oracle Corporation (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Parexel International (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Covance (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 CRF Health (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Science 37 (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Veristat (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Clinical Ink (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Evidation Health (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY STUDY DESIGN
3. 6.3 INDIA MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 INDIA MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 INDIA MARKET ANALYSIS BY PARTICIPANT RECRUITMENT
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY STUDY DESIGN, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY STUDY DESIGN, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY THERAPEUTIC AREA, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY PARTICIPANT RECRUITMENT, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY PARTICIPANT RECRUITMENT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY STUDY DESIGN, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Million)
  4. 7.2.4 BY PARTICIPANT RECRUITMENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Life Sciences Market Segmentation

Life Sciences By Study Design (USD Million, 2025-2035)

Interventional Trials
Observational Trials
Registry Trials
Diagnostic Trials

Life Sciences By Technology (USD Million, 2025-2035)

Wearable Technology
Mobile Health Applications
Telemedicine Platforms
Blockchain Technology

Life Sciences By Therapeutic Area (USD Million, 2025-2035)

Oncology
Cardiology
Neurology
Infectious Diseases
Endocrinology

Life Sciences By Participant Recruitment (USD Million, 2025-2035)

Direct to Patient
Doctor Referrals
Online Platforms
Patient Registries

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”